NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence | The EMBO Journal
Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases | Pharmaceutical Patent Analyst
Targeting IκappaB kinases for cancer therapy. - Abstract - Europe PMC
NF-κB in the crosshairs: Rethinking an old riddle - ScienceDirect
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof-of-concept study - Osteoarthritis and Cartilage
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
Clinical small molecules inhibitors targeting IKK complex in NF-κB pathway. | Download Scientific Diagram
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports